UB Paderborn / Katalog / Suche / in CDI

1 – 24 von 24

Sortiert nach

Low-Density Lipoprotein Cholesterol Lowering With Evolocumab and Outcomes in Patients With Peripheral Artery Disease: Insights From the FOURIER Trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk)

Circulation (New York, N.Y.), 2018-01, Vol.137 (4), p.338-350

2018

Volltextzugriff (PDF)

Clinical Benefit of Evolocumab by Severity and Extent of Coronary Artery Disease: Analysis From FOURIER

Circulation (New York, N.Y.), 2018-08, Vol.138 (8), p.756-766

2018

Volltextzugriff (PDF)

The Effect of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibition on the Risk of Venous Thromboembolism

Circulation (New York, N.Y.), 2020-05, Vol.141 (20), p.1600-1607

2020

Volltextzugriff (PDF)

Predicting Benefit From Evolocumab Therapy in Patients With Atherosclerotic Disease Using a Genetic Risk Score: Results From the FOURIER Trial

Circulation (New York, N.Y.), 2020-02, Vol.141 (8), p.616-623

2020

Volltextzugriff (PDF)

D-Dimer Predicts Long-Term Cause-Specific Mortality, Cardiovascular Events, and Cancer in Patients With Stable Coronary Heart Disease: LIPID Study

Circulation (New York, N.Y.), 2018-08, Vol.138 (7), p.712-723

2018

Volltextzugriff (PDF)

Effect of fenofibrate on amputation events in people with type 2 diabetes mellitus (FIELD study): a prespecified analysis of a randomised controlled trial

The Lancet (British edition), 2009-05, Vol.373 (9677), p.1780-1788

2009

Volltextzugriff (PDF)

Balloon warming time is the strongest predictor of late pulmonary vein electrical reconnection following cryoballoon ablation for atrial fibrillation

Heart rhythm, 2013-09, Vol.10 (9), p.1311-1317

2013

Volltextzugriff (PDF)

Association of Contemporary Sensitive Troponin I Levels at Baseline and Change at 1 Year With Long-Term Coronary Events Following Myocardial Infarction or Unstable Angina: Results From the LIPID Study (Long-Term Intervention With Pravastatin in Ischaemic Disease)

Journal of the American College of Cardiology, 2014-02, Vol.63 (4), p.345-354

2014

Volltextzugriff (PDF)

Clinical Application of a Novel Genetic Risk Score for Ischemic Stroke in Patients With Cardiometabolic Disease

Circulation (New York, N.Y.), 2021-02, Vol.143 (5), p.470-478

2021

Volltextzugriff (PDF)

The risk of fractures associated with thiazolidinediones: a self-controlled case-series study

PLoS medicine, 2009-09, Vol.6 (9), p.e1000154

2009

Volltextzugriff (PDF)

Biomarkers in stable coronary heart disease, their modulation and cardiovascular risk: The LIPID biomarker study

International journal of cardiology, 2015-12, Vol.201, p.499-507

2015

Volltextzugriff (PDF)

Opposite associations between alanine aminotransferase and γ-glutamyl transferase levels and all-cause mortality in type 2 diabetes: analysis of the fenofibrate intervention and event lowering in diabetes (FIELD) study

Metabolism, clinical and experimental, 2016-05, Vol.65 (5), p.783-793

2016

Volltextzugriff (PDF)

Using the EQ-5D Index Score as a Predictor of Outcomes in Patients with Type 2 Diabetes

Medical care, 2009-01, Vol.47 (1), p.61-68

2009

Volltextzugriff (PDF)

The Index of Microcirculatory Resistance Predicts Myocardial Infarction Related to Percutaneous Coronary Intervention

Circulation. Cardiovascular interventions, 2012-08, Vol.5 (4), p.515-522

2012

Volltextzugriff (PDF)

Is home warfarin self-management effective? Results of the randomised Self-Management of Anticoagulation Research Trial

International journal of cardiology, 2013-10, Vol.168 (6), p.5378-5384

2013

Volltextzugriff (PDF)

Cigarette smoking and albuminuria are associated with impaired arterial smooth muscle function in patients with type 2 diabetes mellitus: a FIELD substudy

Diabetes research and clinical practice, 2014-11, Vol.106 (2), p.328-336

2014

Volltextzugriff (PDF)

Genetic Risk Score to Identify Risk of Venous Thromboembolism in Patients With Cardiometabolic Disease

Circulation. Genomic and precision medicine, 2021-02, Vol.14 (1), p.e003006-e003006

2021

Volltextzugriff (PDF)

Lipoprotein(a), PCSK9 Inhibition, and Cardiovascular Risk

Circulation (New York, N.Y.), 2019-03, Vol.139 (12), p.1483-1492

2019

Volltextzugriff (PDF)

First-Line First? Trends in Thiazide Prescribing for Hypertensive Seniors

PLoS medicine, 2005-04, Vol.2 (4), p.e80-e80, Article e80

2005

Volltextzugriff (PDF)

Effect of pravastatin on coronary disease events in subgroups defined by coronary risk factors : The prospective pravastatin pooling project

Circulation (New York, N.Y.), 2000-10, Vol.102 (16), p.1893-1900

2000

Volltextzugriff (PDF)

Safety and tolerability of Pravastatin in long-term clinical trials: Prospective Pravastatin Pooling (PPP) project

Circulation (New York, N.Y.), 2002-05, Vol.105 (20), p.2341-2346

2002

Volltextzugriff (PDF)

Relationship between lipid levels and clinical outcomes in the Long-Term Intervention with Pravastatin in Ischemic Disease (LIPID): Trial to what extent is the reduction in coronary events with Pravastatin explained by on-study lipid levels?

Circulation (New York, N.Y.), 2002-03, Vol.105 (10), p.1162-1169

2002

Volltextzugriff (PDF)

Coronary heart disease in patients with low LDL-cholesterol: Benefit of pravastatin in diabetics and enhanced role for HDL-cholesterol and triglycerides as risk factors

Circulation (New York, N.Y.), 2002-03, Vol.105 (12), p.1424-1428

2002

Volltextzugriff (PDF)

Effects of the vasopeptidase inhibitor, omapatrilat, in 723 patients with coronary heart disease

Journal of the renin-angiotensin-aldosterone system, 2002-12, Vol.3 (4), p.270-276

Neal, Bruce

2002

Volltextzugriff (PDF)

1 – 24 von 24

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieThe New England Journal Of Medicine

ThemaCardiovascular Disease

KollektionIngentaConnect Journals

ThemaAged

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(24)
Mit Volltextzugriff
(24)

Publikationsform

Artikel
(24)

Sprache

Englisch
(24)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

Humans
(24)
Life Sciences & Biomedicine
(23)
Science & Technology
(23)
Female
(22)
Male
(22)
Middle Aged
(21)
Cardiovascular System & Cardiology
(17)
Cardiac & Cardiovascular Systems
(16)
Risk Factors
(16)
Peripheral Vascular Disease
(11)
Treatment Outcome
(10)
Adult
(8)
Anticholesteremic Agents - Therapeutic Use
(8)
Biological And Medical Sciences
(8)
Cholesterol, Ldl - Blood
(8)
Medical Sciences
(8)
Risk Assessment
(8)
Biomarkers - Blood
(7)
Double-Blind Method
(7)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Low-Density Lipoprotein Cholesterol Lowering With Evolocumab and Outcomes in Patients With Peripheral Artery Disease: Insights From the FOURIER Trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk)

Clinical Benefit of Evolocumab by Severity and Extent of Coronary Artery Disease: Analysis From FOURIER

The Effect of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibition on the Risk of Venous Thromboembolism

Predicting Benefit From Evolocumab Therapy in Patients With Atherosclerotic Disease Using a Genetic Risk Score: Results From the FOURIER Trial

D-Dimer Predicts Long-Term Cause-Specific Mortality, Cardiovascular Events, and Cancer in Patients With Stable Coronary Heart Disease: LIPID Study

Effect of fenofibrate on amputation events in people with type 2 diabetes mellitus (FIELD study): a prespecified analysis of a randomised controlled trial

Balloon warming time is the strongest predictor of late pulmonary vein electrical reconnection following cryoballoon ablation for atrial fibrillation

Association of Contemporary Sensitive Troponin I Levels at Baseline and Change at 1 Year With Long-Term Coronary Events Following Myocardial Infarction or Unstable Angina: Results From the LIPID Study (Long-Term Intervention With Pravastatin in Ischaemic Disease)

Clinical Application of a Novel Genetic Risk Score for Ischemic Stroke in Patients With Cardiometabolic Disease

The risk of fractures associated with thiazolidinediones: a self-controlled case-series study

Biomarkers in stable coronary heart disease, their modulation and cardiovascular risk: The LIPID biomarker study

Opposite associations between alanine aminotransferase and γ-glutamyl transferase levels and all-cause mortality in type 2 diabetes: analysis of the fenofibrate intervention and event lowering in diabetes (FIELD) study

Using the EQ-5D Index Score as a Predictor of Outcomes in Patients with Type 2 Diabetes

The Index of Microcirculatory Resistance Predicts Myocardial Infarction Related to Percutaneous Coronary Intervention

Is home warfarin self-management effective? Results of the randomised Self-Management of Anticoagulation Research Trial

Cigarette smoking and albuminuria are associated with impaired arterial smooth muscle function in patients with type 2 diabetes mellitus: a FIELD substudy

Genetic Risk Score to Identify Risk of Venous Thromboembolism in Patients With Cardiometabolic Disease

Lipoprotein(a), PCSK9 Inhibition, and Cardiovascular Risk

First-Line First? Trends in Thiazide Prescribing for Hypertensive Seniors

Effect of pravastatin on coronary disease events in subgroups defined by coronary risk factors : The prospective pravastatin pooling project

Safety and tolerability of Pravastatin in long-term clinical trials: Prospective Pravastatin Pooling (PPP) project

Relationship between lipid levels and clinical outcomes in the Long-Term Intervention with Pravastatin in Ischemic Disease (LIPID): Trial to what extent is the reduction in coronary events with Pravastatin explained by on-study lipid levels?

Coronary heart disease in patients with low LDL-cholesterol: Benefit of pravastatin in diabetics and enhanced role for HDL-cholesterol and triglycerides as risk factors

Effects of the vasopeptidase inhibitor, omapatrilat, in 723 patients with coronary heart disease

Aktive Filter

Suchergebnisse filtern